CurrentEndo
Get Weekly

CurrentEndo coverage · page 5 of 55

Diabetes, Obesity and Metabolism

Briefs 161–200 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Economic Burden of Overweight and Obesity in Sweden: Current Estimates and Future Projections

    Research articleObesity

  2. Diabetes Obes Metab

    Prevalence, Incidence and Mortality of Chronic Kidney Disease in Type 1 and Type 2 Diabetes—A Nationwide Danish Register‐Based Cohort Study

    Cohort studyComplications

  3. Diabetes Obes Metab

    Validation and Comparison of 10‐Year Cardiovascular Risk Prediction Models in Two Chinese Prospective Cohorts: The General Population and Patients With Type 2 Diabetes

    Diagnostic or prognostic studyT2D & other

  4. Diabetes Obes Metab

    Real‐World Effectiveness and Treatment Patterns of Tirzepatide in a Large UK Digital Health Cohort

    Cohort studyObesity

  5. Diabetes Obes Metab

    Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real‐World National Study

    Cohort studyT2D & other

  6. Diabetes Obes Metab

    Long‐Term Follow‐Up Incidence of Type 1 Diabetes and Associated Autoimmune Diseases in First‐Degree Relatives

    Cohort studyT1D

  7. Diabetes Obes Metab

    Time to Insulin Initiation Among Patients With Type 2 Diabetes Treated With Second‐Line Antidiabetic Drugs

    Cohort studyT2D & other

  8. Diabetes Obes Metab

    Efficacy and Hypoglycaemia Outcomes With Once‐Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1–3 Trials

    Secondary analysisT2D & other

  9. Diabetes Obes Metab

    The ‘Slow Burn’ Phenotype: How Relative Caloric Intake Reveals Hidden Cardiovascular Risk Beyond BMI

    Cohort studyObesity

  10. Diabetes Obes Metab

    Factors Associated With Progression From Level 1 to Level 2 Sensor‐Detected Hypoglycaemia in People With Type 1 and Insulin‐Treated Type 2 Diabetes: A Post Hoc Analysis From the Hypo‐ METRICS Study

    Secondary analysisComplications

  11. Diabetes Obes Metab

    GLP ‐1 Receptor Agonist Therapy for Obesity Under Japan's Optimal Use Guideline: A Prospective Real‐World Study of Lifestyle Pre‐Treatment, Time‐Limited Treatment Cap, and Post‐Cessation Regain

    Cohort studyObesity

  12. Diabetes Obes Metab

    SGLT2 Inhibitor Use in Type 2 Diabetes in England: A Population‐Based Cross‐Sectional Study of Uptake of NICE Guidance

    Cross-sectional studyT2D & other

  13. Diabetes Obes Metab

    Absence of Interaction Between 5α‐Reductase Inhibitors and Glucocorticoids on Incidence of Myocardial Infarction in People With Type 2 Diabetes

    Cohort studyT2D & other

  14. Diabetes Obes Metab

    An Evening Activity Breaks Intervention for Improvement of Glucose, Blood Pressure, and Sleep: A Pilot Study in Free‐Living Adults

    Research articleT2D & other

  15. Diabetes Obes Metab

    Metabolic Stress Testing Reveals Persistent Lipid‐Handling Dysfunction in Women With Polycystic Ovary Syndrome Despite Exercise Training

    Mechanistic studyReproductive endocrine

  16. Diabetes Obes Metab

    α ‐Hydroxybutyrate Association With Incident Type 2 Diabetes Over 10 Years Across Different Glycemic States

    Cohort studyT2D & other

  17. Diabetes Obes Metab

    Identification of Activity, Insulin, and Dietary Thresholds Associated With Exercise‐Related Hypoglycaemia and Hyperglycaemia in Children With Type 1 Diabetes: A Free‐Living Study Using Explainable Machine Learning

    Cohort studyT1D

  18. Diabetes Obes Metab

    Socioeconomic and Linguistic Factors in Paediatric Type 1 Diabetes: Exploring Glycemic Outcomes, Technology Use, and Residual Beta‐Cell Function in Migrant‐Background Populations

    Cohort studyT1D

  19. Diabetes Obes Metab

    Projecting the Long‐Term Cost‐Effectiveness of Once‐Weekly Insulin Icodec Versus Once‐Daily Basal Insulin Analogs in Italy Using the Prime T2D Model

    Research articleT2D & other

  20. Diabetes Obes Metab

    Feasibility of Decentralised Response‐Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease

    Research articleT2D & other

  21. Diabetes Obes Metab

    A New Highly Concentrated Insulin Aspart AT278 (500 U/ mL ) Demonstrates Ultra‐Rapid Pharmacokinetic and Pharmacodynamic Properties in Type 2 Diabetes Regardless of BMI

    Randomized controlled trialT2D & other

  22. Diabetes Obes Metab

    Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta‐Analysis

    Meta-analysisT2D & other

  23. Diabetes Obes Metab

    Efficacy and Safety of Bimagrumab in Adults With Obesity and Metabolic Dysfunction: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

    Meta-analysisObesity

  24. Diabetes Obes Metab

    Beyond Glycaemia: Fear of Hypoglycaemia, Cognition and Functional Mobility After Advanced Hybrid Closed‐Loop Therapy in Older Adults With Type 1 Diabetes: A Prespecified Secondary Analysis of a Randomised, Single‐Centre Study

    Secondary analysis

  25. Diabetes Obes Metab

    Economic Burden of Type 1 Diabetes in France

    Cross-sectional studyT1D

  26. Diabetes Obes Metab

    Real‐World Effectiveness and Safety of Finerenone in People With Type 2 Diabetes and Chronic Kidney Disease: A Spanish Multicentre Retrospective Observational Study ( MEDFINE ‐ RWD )

    Cohort studyComplications

  27. Diabetes Obes Metab

    Refining the Genetic Contribution to Type 2 Diabetes Subtypes

    Diagnostic or prognostic studyT2D & other

  28. Diabetes Obes Metab

    Impact of Albuminuria‐Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials

    Secondary analysisComplications

  29. Diabetes Obes Metab

    Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone

    Cohort studyT2D & other

  30. Diabetes Obes Metab

    Cardiovascular Autonomic Neuropathy and Indices of Heart Failure in Type 2 Diabetes: The CANCAN Study

    Cross-sectional studyComplications

  31. Diabetes Obes Metab

    Economic Impact of Multidisciplinary Pre‐operative Diabetes Care Versus Usual Care in Adults Undergoing Elective Non‐cardiac Surgery in Australia: A Trial‐Based Analysis

    Cohort studyT2D & other

  32. Diabetes Obes Metab

    GLP ‐1 Receptor Agonists and Risk of Skin Cancer in Adults With Type 2 Diabetes: A Target Trial Emulation

    Research articleT2D & other

  33. Diabetes Obes Metab

    Low‐Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non‐Diabetic Japanese Adults

    Cohort studyObesity

  34. Diabetes Obes Metab

    Sustained Use of SGLT2 Inhibitors and Cardiovascular Outcomes in Older Adults: A Landmark Cohort Study

    Cohort studyT2D & other

  35. Diabetes Obes Metab

    Efficacy of CagriSema for Reaching Anthropometric Treatment Targets and Cardiometabolic Outcomes: A Secondary, Post hoc Analysis of REDEFINE 1

    Secondary analysisObesity

  36. Diabetes Obes Metab

    Efficacy and Safety of Once‐Weekly Semaglutide 2.0 mg as an Add‐On to Dose‐Reduced Insulin Glargine versus Dose‐Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight ( SUSTAIN OPTIMIZE )

    Randomized controlled trialT2D & other

  37. Diabetes Obes Metab

    A UK Healthcare Professional Perspective on the Implementation of Monitoring in Children and Young People With Early‐Stage Type 1 Diabetes: A Qualitative Study

    Research articleT1D

  38. Diabetes Obes Metab

    Exercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non‐Insulin Treated Type 2 Diabetes: A Randomised Trial

    Randomized controlled trialT2D & other

  39. Diabetes Obes Metab

    Real‐World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm ( APGO ) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study

    Cohort studyT1D

  40. Diabetes Obes Metab

    Large‐Scale Plasma Proteomics Enhances Prediction of Liver‐Related Events Among Individuals With Prediabetes and Type 2 Diabetes: A Prospective Cohort Study in the UK Biobank

    Cohort studyT2D & other

All 2,200 Briefs in ExploreShowing Briefs 161–200 of 2,200, newest first